1 |
Kaur P, Gunawardena N, Kumaresan J. A review of chronic kidney disease of unknown etiology in Sri Lanka, 2001-2015 [J]. Indian J Nephrol, 2020, 30(4): 245-252.
|
2 |
Zhang Z, Yuan X, Wu Y, et al. The family attitudes of patients with end-stage renal disease toward living kidney donation in China [J]. Transplant Proc, 2020, 52(5): 1360-1364.
|
3 |
Chen JC, Thorsteinsdottir B, Vaughan LE, et al. End of life, withdrawal, and palliative care utilization among patients receiving maintenance hemodialysis therapy [J]. Clin J Am Soc Nephrol, 2018, 13(8): 1172-1179.
|
4 |
Liu Y, Wang L, Han X, et al. The profile of timing dialysis initiation in patients with end-stage renal disease in China: a cohort study [J]. Kidney Blood Press Res, 2020, 45(2): 180-193.
|
5 |
Kuswardhani RT, Wiradharma KG, Kandarini Y, et al. Factors associated with carotid intima-media thickness in patients on maintenance hemodialysis [J]. Int J Gen Med, 2018, 12: 1-6.
|
6 |
高洁, 茅一萍. 门诊血液透析患者血液感染的流行病学研究进展 [J]. 中华医院感染学杂志, 2020, 30(12): 1915-1920.
|
7 |
Aissaoui H, Hdidou Y, Bougrine R, et al. Infective endocarditis caused by klebsiella oxytoca in a patient with hemodialysis: a care-compliant case report and review of the literature [J].J Saudi Heart Assoc, 2020, 32(2): 307-310.
|
8 |
Bentata Y. Physiopathological approach to infective endocarditis in chronic hemodialysis patients: left heart versus right heart involvement [J]. Ren Fail, 2017, 39(1): 432-439.
|
9 |
Spaleniak S, Lubas A, Kade G, et al. Infective endocarditis in chronic hemodialysis patients is it still a growing clinical challenge [J]? Pol Merkur Lekarski, 2019, 46(272): 64-67.
|
10 |
Wang CY, Wang YC, Yang YS, et al. Microbiological features, clinical characteristics and outcomes of infective endocarditis in adults with and without hemodialysis: a 10-year retrospective study in Northern Taiwan [J]. J Microbiol Immunol Infect, 2020, 53(2): 336-343.
|
11 |
Isakova T, Nickolas TL, Denburg M, et al. KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) [J]. Am J Kidney Dis, 2017, 70(6): 737-751.
|
12 |
Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM) [J]. Eur Heart J, 2015, 36(44): 3075-3128.
|
13 |
National Kidney Foundation. KDOQI clinical practice guideline for diabetes and CKD: 2012 update [J]. Am J Kidney Dis, 2012, 60(5): 850-886.
|
14 |
Flack JM, Calhoun D, Schiffrin EL. The new ACC/AHA hypertension guidelines for the prevention, detection, evaluation, and management of high blood pressure in adults [J]. Am J Hypertens, 2018, 31(2): 133-135.
|
15 |
American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019 [J]. Diabetes Care, 2019, 42(Suppl 1): S13-S28.
|
16 |
Unger T, Borghi C, Charchar F, et al. 2020 international society of hypertension global hypertension practice guidelines [J]. Hypertension, 2020, 75(6): 1334-1357.
|
17 |
Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons [J]. Circulation, 2012, 126(25): 3097-3137.
|
18 |
Fisher JD. New York Heart Association Classification [J]. Arch Intern Med, 1972, 129(5): 836.
|
19 |
吴珍珠, 陈意, 肖婷婷, 等. 存在和不存在基础心脏病的感染性心内膜炎患者临床特点及预后的比较研究 [J]. 中国循环杂志, 2019, 34(4): 375-380.
|
20 |
李杨, 王中素, 刘鲁祁, 等. 某三甲医院80例感染性心内膜炎患者临床特征及内外科疗效比较 [J]. 山东大学学报(医学版), 2020, 58(6): 22-27.
|
21 |
漆敏, 刘晓晓, 陈君, 等. 湘雅医院430例感染性心内膜炎患者的临床特征及治疗 [J]. 中国感染控制杂志, 2020, 19(6): 539-545.
|
22 |
邢燕姬, 林海丽, 王海珠, 等. 感染性心内膜炎老年患者的临床表现与死亡影响因素分析 [J]. 中华医院感染学杂志, 2019, 29(19): 2948-2952.
|
23 |
倪国华, 贾斌, 王宝珠, 等. 161例感染性心内膜炎患者临床特征及预后因素分析 [J]. 新疆医科大学学报, 2019, 42(9): 1159-1162.
|
24 |
Heredia-Rodríguez M, Bustamante-Munguira J, Lorenzo M, et al. Procalcitonin and white blood cells, combined predictors of infection in cardiac surgery patients [J]. J Surg Res, 2017, 212: 187-194.
|
25 |
Kristono GA, Holley AS, Harding SA, et al. White blood cell subtypes as predictors of adverse cardiac events [J]. Coron Artery Dis, 2020, 31(5): 446-450.
|
26 |
Holcman K, Małecka B, Rubiś P, et al. The role of 99mTc-HMPAO-labelled white blood cell scintigraphy in the diagnosis of cardiac device-related infective endocarditis [J]. Eur Heart J Cardiovasc Imaging, 2020, 21(9): 1022-1030.
|
27 |
Hamilton-Elliott J, Ambrose E, Christley R, et al. White blood cell differentials in dogs with congestive heart failure (CHF) in comparison to those in dogs without cardiac disease [J]. J Small Anim Pract, 2018, 59(6): 364-372.
|
28 |
Jacob KA, Buijsrogge MP, Frencken JF, et al. White blood cell count and new-onset atrial fibrillation after cardiac surgery [J]. Int J Cardiol, 2017, 228: 971-976.
|
29 |
田荣荣, 张红梅, 常立阳. 血液透析患者蛋白质摄入量的研究进展 [J]. 中国血液净化, 2020, 19(4): 256-258.
|
30 |
李霞, 李转欢, 邓玲珠, 等. 维持性血液透析患者血红蛋白变异度和血清白蛋白的相关性 [J]. 中国医师杂志, 2020, 25(10): 1520-1523.
|
31 |
张晓艳. 老年维持血液透析患者血红蛋白水平对心血管不良事件发生的影响 [J]. 中国老年学杂志, 2017, 37(11): 2789-2791.
|
32 |
王文秋, 马玉环, 袁艳华, 等. 腹膜透析患者血清白蛋白、铁调素25及25羟维生素D与动脉僵硬度的相关性研究 [J]. 标记免疫分析与临床, 2018, 25(9): 1293-1296.
|
33 |
撒利建, 马蓓佳, 赵瑛瑛. 不同腹膜透析龄患者血红蛋白变异性与心脏结构及功能相关性分析 [J]. 中华实用诊断与治疗杂志, 2019, 33(1): 43-46.
|